Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Anzalone Christopher RichardCEO |
Sell | 4,634 @ $30.74 | $142,449 | 3,720,366 | 01/02/2024 | 01/04/2024 | |
Anzalone Christopher RichardCEO |
Sell | 5,318 @ $31.25 | $166,188 | 3,715,048 | 01/02/2024 | 01/04/2024 | |
Anzalone Christopher RichardCEO |
Sell | 12,000 @ $28.54 | $342,480 | 3,725,000 | 12/20/2023 | 12/22/2023 | |
San Martin JavierChief Medical Officer |
Sell | 14,758 @ $28.73 | $423,997 | 136,742 | 11/20/2023 | 11/22/2023 | |
San Martin JavierChief Medical Officer |
Sell | 4,942 @ $29.00 | $143,318 | 131,800 | 11/20/2023 | 11/22/2023 | |
Anzalone Christopher RichardCEO |
Sell | 24,338 @ $24.21 | $589,223 | 3,737,000 | 10/25/2023 | 10/27/2023 | |
Vakiener Victoriadirector |
Sell | 1,550 @ $26.33 | $40,812 | 21,734 | 09/28/2023 | 10/02/2023 | |
Anzalone Christopher RichardCEO |
Sell | 31,523 @ $28.00 | $882,644 | 3,787,570 | 09/18/2023 | 09/20/2023 | |
Anzalone Christopher RichardCEO |
Sell | 26,232 @ $28.27 | $741,579 | 3,761,338 | 09/18/2023 | 09/20/2023 | |
Oliver TracieChief Commercial Officer |
Sell | 8,925 @ $35.31 | $315,142 | 61,575 | 07/03/2023 | 07/06/2023 | |
Hamilton James C |
Sell | 3,000 @ $35.53 | $106,590 | 188,484 | 06/30/2023 | 07/05/2023 | |
Myszkowski Kenneth AllenCFO |
Sell | 15,000 @ $36.20 | $543,000 | 381,704 | 06/27/2023 | 06/29/2023 | |
GIVEN DOUGLAS Bdirector |
Sell | 6,500 @ $40.90 | $265,850 | 117,635 | 05/05/2023 | 05/08/2023 | |
Anzalone Christopher RichardCEO |
Sell | 24,008 @ $38.97 | $935,592 | 3,787,330 | 05/04/2023 | 05/05/2023 | |
Anzalone Christopher RichardCEO |
Sell | 25,992 @ $40.02 | $1.04 M | 3,761,338 | 05/04/2023 | 05/05/2023 | |
Anzalone Christopher RichardCEO |
Sell | 54,928 @ $39.14 | $2.15 M | 3,761,338 | 05/03/2023 | 05/05/2023 | |
OLUKOTUN ADEOYE Ydirector |
Sell | 11,350 @ $32.65 | $370,578 | 7,867 | 03/03/2023 | 03/06/2023 | |
GIVEN DOUGLAS Bdirector |
Sell | 875 @ $32.62 | $28,543 | 13,000 | 02/27/2023 | 03/01/2023 | |
Waddill William D.director |
Sell | 3,200 @ $30.00 | $96,000 | 28,950 | 01/09/2023 | 01/11/2023 | |
O'Brien PatrickCOO and General Counsel |
Sell | 7,500 @ $37.39 | $280,425 | 413,375 | 01/05/2023 | 01/06/2023 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at Arrowhead Pharmaceuticals, Inc. includes Anzalone Christopher Richard, Vakiener Victoria, San Martin Javier, O'Brien Patrick, Hamilton James C, Myszkowski Kenneth Allen, Oliver Tracie, Ferrari Mauro, Waddill William D., GIVEN DOUGLAS B, Lu Hongbo.
A. Insiders have sold a total of 349,359 Arrowhead Pharmaceuticals, Inc. shares in the last 12 months for a total of 11.14 M sold.
A. The following insiders have sold Arrowhead Pharmaceuticals, Inc. shares in the last 12 months: Anzalone Christopher Richard ($4.72 M), Vakiener Victoria ($262,560), San Martin Javier ($860,119), O'Brien Patrick ($1.14 M), Hamilton James C ($1.79 M), Myszkowski Kenneth Allen ($1.98 M), Oliver Tracie ($2,508), Ferrari Mauro ($119,787), Waddill William D. ($149,759), GIVEN DOUGLAS B ($110,788),
A. Insiders have purchased a total of 3,000 Arrowhead Pharmaceuticals, Inc. shares in the last 12 months for a total of 82,990 sold.
A. The following insiders have purchased Arrowhead Pharmaceuticals, Inc. shares in the last 12 months: Lu Hongbo ($82,990),